Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Harbour BioMeda global biopharmaceutical company committed to the discovery development and commercialization of novel antibody therapeutics focusing on oncology and immunology today announced the submission of an Investigational New Drug
Illumina Hong Kong LIMITED Illumina a global leader in DNA sequencing and arraybased technologies and PHASE Scientific International Limited PHASE a Hong Kongbased biotech company with operations in the US and the Greater Bay Area
Harbinger Health a biotechnology company pioneering new technologies to fundamentally change cancer screening and detection today announced a new collaboration with Memorial Sloan Kettering Cancer Center MSK one of the worlds largest leading cancer c...
Avid Bioservices Inc a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies
BioIVT a global research partner and biospecimen solutions provider for drug and diagnostic development today announced an exclusive agreement with KRISHGEN BioSystems a leading provider of life science research tools and services
The European Medicines Agency has approved Dupixent dupilumab to treat eosinophilic esophagitis EoE in children as young as one year of age Specifically the approval covers children aged one to years who weigh at least kg and who are inadequately c...
Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard are collaborating on a project to tackle the urgent and unmet needs of people living with mental health conditions
J INTS BIO hosted a significant MOU signing ceremony at Baekyangnuri Plaza Yonsei University unveiling a groundbreaking AIdriven collaboration to revolutionize
Surrozen Inca company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration today announced a strategic research collaboration with privatelyheld TCGFB Inc
NeuroBo Pharmaceuticals Inc a clinicalstage biotechnology company focused on transforming cardiometabolic diseases today announced the completion of the last patient last visit in its twopart Phase a clinical trial evaluating the efficacy and safety...
